Ms Holmes is not the only one implicated in the debacle. For example, Safeway, a grocery chain, and Walgreens, a pharmacy giant, respectively stumped up around $400m and $140m to collaborate with Theranos. According to the SEC, she and Sunny Balwani, her deputy (and, says Mr Carreyrou, secretly her boyfriend), misled investors and other corporations about the state of Theranos’s technology and sales. What went wrong? Mr Carreyrou suggests Ms Holmes cared less for patients than about advancing her own interests and personal brand. A criminal inquiry is believed to be in train. Earlier this year Ms Holmes settled civil charges brought by America’s financial regulator, the Securities and Exchange Commission (SEC), of defrauding investors. It was Mr Carreyrou who first raised questions about Theranos, suggesting in the Wall Street Journal in 2015 that its testing technique yielded unreliable results. “Bad Blood”, an enjoyable book by John Carreyrou, an investigative journalist, charts Ms Holmes’s rise and dramatic fall.
0 Comments
Leave a Reply. |